Clinical Trial Update: NQ TMS for MDD Therapy Using 1 Day x 3 Sessions Protocol for Adult Patient [NA]

View source ↗

Summary

A completed clinical trial update for NQ TMS therapy in adults with Major Depressive Disorder using a 1-day, 3-session protocol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NQ TMS

Snippet

Sponsor: NeuroQore Inc. | Conditions: Major Depressive Disorder (MDD) | NA | Status: COMPLETED